Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. - Wikidata - awgldk - TriplyDB

Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection.

Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection.

http://www.wikidata.org/entity/Q36751523

about

Glycan masking of Plasmodium vivax Duffy Binding Protein for probing protein binding function and vaccine development Preclinical Assessment of Viral Vectored and Protein Vaccines Targeting the Duffy-Binding Protein Region II of Plasmodium Vivax Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria The Duffy binding protein as a key target for a Plasmodium vivax vaccine: lessons from the Brazilian Amazon Platform for Plasmodium vivax vaccine discovery and development Naturally-acquired humoral immune responses against the N- and C-termini of the Plasmodium vivax MSP1 protein in endemic regions of Brazil and Papua New Guinea using a multiplex assay The Presence, Persistence and Functional Properties of Plasmodium vivax Duffy Binding Protein II Antibodies Are Influenced by HLA Class II Allelic Variants Reduced risk of Plasmodium vivax malaria in Papua New Guinean children with Southeast Asian ovalocytosis in two cohorts and a case-control study Structural analysis of the synthetic Duffy Binding Protein (DBP) antigen DEKnull relevant for Plasmodium vivax malaria vaccine design Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children.Naturally acquired antibodies to Plasmodium vivax Duffy binding protein (DBP) in Brazilian Amazon.Mapping epitopes of the Plasmodium vivax Duffy binding protein with naturally acquired inhibitory antibodies.Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies.Plasmodium vivax tryptophan-rich antigen PvTRAg33.5 contains alpha helical structure and multidomain architecture.Blood groups and malaria: fresh insights into pathogenesis and identification of targets for intervention.Determination of the molecular basis for a limited dimorphism, N417K, in the Plasmodium vivax Duffy-binding protein.Strategies for designing and monitoring malaria vaccines targeting diverse antigens Worldwide genetic variability of the Duffy binding protein: insights into Plasmodium vivax vaccine development Evaluation of naturally acquired IgG antibodies to a chimeric and non-chimeric recombinant species of Plasmodium vivax reticulocyte binding protein-1: lack of association with HLA-DRB1*/DQB1* in malaria exposed individuals from the Brazilian Amazon.Advances and challenges in malaria vaccine development.Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysis Fy(a)/Fy(b) antigen polymorphism in human erythrocyte Duffy antigen affects susceptibility to Plasmodium vivax malaria A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines Characterization of inhibitory anti-Duffy binding protein II immunity: approach to Plasmodium vivax vaccine development in Thailand.Immunogenicity of a synthetic vaccine based on Plasmodium vivax Duffy binding protein region II.The epitope of monoclonal antibodies blocking erythrocyte invasion by Plasmodium falciparum map to the dimerization and receptor glycan binding sites of EBA-175.In silico studies on DARC.B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax merozoite surface protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian Amazon.Finding the sweet spots of inhibition: understanding the targets of a functional antibody against Plasmodium vivax Duffy binding protein Duffy antigen receptor for chemokine (DARC) polymorphisms and its involvement in acquisition of inhibitory anti-duffy binding protein II (DBPII) immunity.Preserved dendritic cell HLA-DR expression and reduced regulatory T cell activation in asymptomatic Plasmodium falciparum and P. vivax infection.Design and immunogenicity of a novel synthetic antigen based on the ligand domain of the Plasmodium vivax duffy binding protein.Plasmodium simium, a Plasmodium vivax-related malaria parasite: genetic variability of Duffy binding protein II and the Duffy antigen/receptor for chemokines.Conserved and variant epitopes of Plasmodium vivax Duffy binding protein as targets of inhibitory monoclonal antibodies.Strain-Transcending Inhibitory Antibodies against Homologous and Heterologous Strains of Duffy Binding Protein region II.Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis.A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax.Duffy Blood Group System and the malaria adaptation process in humans Immunogenetic markers associated with a naturally acquired humoral immune response against an N-terminal antigen of Plasmodium vivax merozoite surface protein 1 (PvMSP-1).Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein.

P2860

Q21558777-92C95816-3B24-4EB3-AC7C-71195F717721 Q24273364-492F6091-0FC8-4A69-ABE9-8F81EB52D99C Q26772878-E2D204C3-69D4-45EF-964A-15CC8858482E Q27009149-6F596443-AF6A-4F40-BF99-CE8FD567FA9B Q27021891-2736EB8D-36F9-47A5-9521-8494BD15B03B Q28394065-5C8FD7D7-3CA3-4526-A4A3-1ADDB7C0C9D5 Q28396379-13C3A19D-D983-4C28-BB04-111EDEACFD1F Q28483318-C2D9F187-088D-4E69-8001-AA4F11F10AEB Q28544738-D2B48E46-AF2B-47B2-A241-876E1E193E77 Q33530114-52D1BE58-B12F-40A4-B190-BB8D89FE1C6F Q33617528-00F4D56B-3938-4AFF-A746-25E8545E0D7F Q33676028-536DC421-A09C-4A28-B759-8297E3FD9B0D Q33798074-BEEBFCBE-D2A8-4290-8D32-1140DCD913A6 Q33809115-BDE46953-1A40-4879-A65E-F4BE5B17B189 Q33884976-37C864E9-2407-4428-8C9F-F249C3533478 Q33918156-322F9BD8-D322-42A9-880C-28E667D88068 Q33959038-20E67A31-5CB7-4A5F-98C4-5C0838B7C341 Q33988630-7586BF61-0CAD-40D2-9FFE-BBD9617C4BB0 Q34078790-EFDCE53C-33BB-4C6D-B520-6C5750177B78 Q34145333-0A12FFF7-42DF-4055-8019-8AFBFE251651 Q34234390-FC48569C-5F7F-48E3-B771-1247D244714C Q34236565-9351288D-4129-4E67-9CC6-092F4747DE99 Q34254934-10C92CAD-C84C-41D7-A02D-135B24C37775 Q34256740-88C8930E-989A-4F12-93F1-76D976C50D62 Q34260750-114B6288-8235-4746-BF8F-106E4FADDC8A Q34606720-039ADC55-14F0-4E2A-B247-36858898419A Q34658695-5CF3197E-CF0E-4788-A26E-50145D733C3B Q34726966-2888C7A0-5F67-4457-BC0B-45BB739CCA0B Q34994491-041BF593-BD88-4346-A0FA-60435673F011 Q35141958-8F89C475-4402-4B19-8D6C-5872492B178E Q35649424-71224C8D-48BD-4E46-B4ED-344C2E618D57 Q35666191-39F6F135-FCC5-4C16-8D99-B72D343D4716 Q35673121-D2F4253B-0227-4BB2-8031-57DCFDBE7177 Q35805433-B6257B0B-A9AA-418B-92CE-2B03B763A608 Q36008345-FD08D146-86BE-4D7F-BAFC-6CB050665C0C Q36114619-BFE70CFC-D04B-492F-B132-D759FE43DA32 Q36225497-7C86B323-E0F6-45DC-8AB8-4E4D59FDED92 Q36464343-3FB4A391-FCB6-4079-8F9E-4A4E0169B388 Q36965601-C95C5EE5-E72C-4DBC-9691-6AB605A2438A Q36978206-48E493F4-BF8B-4F5F-AB39-8C8990714349

P2860

Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection.

http://www.wikidata.org/entity/Q36751523

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Naturally acquired Duffy-bindi ...... ge Plasmodium vivax infection.

@en

type

label

Naturally acquired Duffy-bindi ...... ge Plasmodium vivax infection.

@en

prefLabel

Naturally acquired Duffy-bindi ...... ge Plasmodium vivax infection.

@en

P1433

Q36751523-43731475-4CBE-4038-946E-9A5BF92674CC

P1476

Q36751523-92E26C97-A036-48FE-B822-5209F4717781

P2093

Q36751523-1C07643B-9311-46E1-B353-8DE8395665C8

Q36751523-3A3A46AB-2F6C-401E-A3F1-FE95CAA0FA6A

Q36751523-562BB789-4617-4552-99E7-3BF0EB4960B8

Q36751523-809CD285-3B84-460E-B8CE-548559E326AC

Q36751523-B07FDEF2-A7BC-40C7-8DC7-56314B1BD563

Q36751523-B4D20EA8-7764-4E1E-B7B3-0311D001810B

P2860

Q36751523-052287B2-664D-4081-BD5D-3547F97812D0

Q36751523-0743C22A-EFBB-4BDE-8869-8DBF62B5B8B3

Q36751523-093E3072-6AA0-40E3-A4F5-A4C24D4522A3

Q36751523-16C70527-A7A4-4E51-9885-A05878A19A0A

Q36751523-1E0383E6-8C74-446D-89B5-A8BD9A2096B7

Q36751523-23A77600-C853-4A47-9281-9781F715365D

Q36751523-24C8431B-E966-48E3-A2C4-CAE40C400A20

Q36751523-27F75647-6E9F-492A-A3F6-38F6068AD9A0

Q36751523-377D269A-A485-4DDE-84B3-6902F7C19AB5

Q36751523-48F61DE7-F8AB-41E3-A298-7840F96FDD56

P304

Q36751523-D1700D25-FBA0-4795-B37A-92E87FE9AB52

P31

Q36751523-4208A314-ACBD-4F50-BAD8-1404E0D75B3F

P356

Q36751523-795FEBDF-0E43-4B1C-A6B1-22D335F79807

P407

Q36751523-5E0DF5AE-D102-4974-B6C0-85C22C7F63A5

P433

Q36751523-AB45B5BB-359A-4081-8CCE-614466818518

P478

Q36751523-8BA42D16-7EC9-40FE-8886-D0FB5A699EE2

P50

Q36751523-011747AD-B63B-4899-9FC5-7267D04F3E14

Q36751523-42321711-291C-4B8B-8143-895D26C38E9A

Q36751523-7380D4B6-189B-42F4-A4F1-501EC549BD4C

P577

Q36751523-348516DA-F01D-4D15-AF61-88E3AD7CC54F

P5875

Q36751523-57E84045-5C9A-42DF-99E9-CF3F47FBB9BD

P698

Q36751523-303C9535-5CF8-4D21-855A-14DEF99AAEDB

P921

Q36751523-14A0E188-FCB7-405C-8607-C3883B2F708F

Q36751523-C21B7B32-7A2B-4F24-8069-D569B7FD2A44

P932

Q36751523-BE8402C0-1190-49A7-8594-292D06DE249E

P356

PNAS.0800371105

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Naturally acquired Duffy-bindi ...... ge Plasmodium vivax infection.

@en

P2093

Ahmad Rushdi Shakri

http://www.w3.org/2001/XMLSchema#string

Alexandra Marcotty

http://www.w3.org/2001/XMLSchema#string

Christopher L King

http://www.w3.org/2001/XMLSchema#string

Danielle Stanisic

http://www.w3.org/2001/XMLSchema#string

Jennifer L Cole-Tobian

http://www.w3.org/2001/XMLSchema#string

Pascal Michon

http://www.w3.org/2001/XMLSchema#string

P2860

The Resistance Factor to Plasmodium vivax in Blacks

Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein

A family of erythrocyte binding proteins of malaria parasites.

A challenge for the development of malaria vaccines: polymorphic target antigens.

The Duffy receptor family of Plasmodium knowlesi is located within the micronemes of invasive malaria merozoites.

Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion

Plasmodium vivax interaction with the human Duffy blood group glycoprotein: identification of a parasite receptor-like protein.

Reduced Plasmodium vivax erythrocyte infection in PNG Duffy-negative heterozygotes

Host age as a determinant of naturally acquired immunity to Plasmodium falciparum.

The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes.

P304

8363-8368

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0800371105

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

Peter A Zimmerman

Chetan E Chitnis

P577

2008-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51399395

http://www.w3.org/2001/XMLSchema#string

P698

18523022

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium vivax

P932

2448842

http://www.w3.org/2001/XMLSchema#string